<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072795</url>
  </required_header>
  <id_info>
    <org_study_id>00111432</org_study_id>
    <secondary_id>3U54DA016511-19S1</secondary_id>
    <nct_id>NCT05072795</nct_id>
  </id_info>
  <brief_title>Stress-Reactivity and Cannabis Use in Cannabis-Using Older Adults</brief_title>
  <acronym>PUMA</acronym>
  <official_title>MUSC Specialized Center of Research Excellence (SCORE) on Sex Differences: Stress-Reactivity and Cannabis Use in Cannabis-Using Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to evaluate how cannabis use affects memory and thinking skills and&#xD;
      response to stress in older adults. The study will also relate cannabis use to Alzheimer's&#xD;
      Disease (AD) biomarkers (measurable substances in blood that indicate condition), and test&#xD;
      whether sex and hormones play a role in these effects. The study is recruiting adults between&#xD;
      the ages of 50 and 80 who use cannabis products on a regular basis. Study participation will&#xD;
      last about two weeks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 20, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global Cognitive Ability (GCA)</measure>
    <time_frame>Day 0 to Day 8</time_frame>
    <description>The primary outcome is the mean Global Cognitive Ability (GCA) z-score, which is a psychometrically robust, factor analytically-derived, demographically-normed index of global cognitive function. Lower z-scores represent a lower level of cognitive function. The investigator will test the hypothesis that women with CUD will have lower GCA scores than men.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cannabis Use</condition>
  <arm_group>
    <arm_group_label>Stress Induction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Trier Social Stress Task (TSST)</intervention_name>
    <description>The TSST is a standardized psychological stress challenge which provokes a stress response in a laboratory setting. During the task, saliva samples will be collected for hormone testing along with physiological and subjective measures.</description>
    <arm_group_label>Stress Induction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 50-80.&#xD;
&#xD;
          -  Women must be &gt;1 year post-menopausal.&#xD;
&#xD;
          -  English as a first/primary language.&#xD;
&#xD;
          -  Functional visual and auditory acuity (aided or unaided) to complete tests.&#xD;
&#xD;
          -  Capacity to independently provide informed consent and function at an intellectual&#xD;
             level sufficient to allow completion of all instruments.&#xD;
&#xD;
          -  Currently meets DSM-5 criteria for CUD.&#xD;
&#xD;
          -  Consent to abstain from alcohol and cannabis use for &gt;12 hours prior to Study Visit&#xD;
             (Day 0), and TSST (Day 8).&#xD;
&#xD;
          -  Consent to abstain from all drugs other than cannabis or nicotine for the duration of&#xD;
             the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Meet DSM-5 criteria for moderate or severe alcohol or substance use disorder (other&#xD;
             than nicotine or cannabis) within the last 12 months.&#xD;
&#xD;
          -  History of major neurocognitive disorder or developmental disorder per DSM-5.&#xD;
&#xD;
          -  A Telephone Interview for Cognitive Status (TICS) score of less than or equal to 22.&#xD;
&#xD;
          -  Significant or unstable medical condition/s that impact cognition as deemed by study&#xD;
             investigators, such as active significant cardiac, cerebrovascular, neoplastic,&#xD;
             infectious, or metabolic disease, or longstanding and intractable severe mental&#xD;
             illness (e.g. schizophrenia spectrum disorder, bipolar disorder).&#xD;
&#xD;
          -  Daily use of medications that adversely impact cognition in aging (i.e.&#xD;
             anticholinergics and sedatives).&#xD;
&#xD;
          -  Current suicidal or homicidal ideation/risk.&#xD;
&#xD;
          -  Unable to complete/comply with procedures or pose threat to research staff.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreana Benitez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aimee Aimee McRae-Clark, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reyna Hickey</last_name>
    <phone>843-792-5573</phone>
    <email>hickeyre@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katrina Madden</last_name>
    <phone>843-792-9186</phone>
    <email>maddenka@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reyna Hickey</last_name>
      <phone>843-792-5573</phone>
      <email>hickeyre@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Katrina Madden</last_name>
      <phone>843-792-9186</phone>
      <email>maddenka@musc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Andreana Benitez, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aimee McRae-Clark, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>October 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Andreana Benitez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

